Immunophenotypic normalization of aberrant mast cells accompanies histological remission in imatinib-treated patients with eosinophilia-associated mastocytosis

被引：16

作者：

Elliott, MA ^{[1
]}

Pardanani, A ^{[1
]}

Li, CY ^{[1
]}

Tefferi, A ^{[1
]}

机构：

[1] Mayo Clin & Mayo Fdn, Rochester, MN 55905 USA

来源：

LEUKEMIA | 2004年 / 18卷 / 05期

关键词：

D O I：

10.1038/sj.leu.2403329

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：1027 / 1029

页数：4

共 6 条

[1] A tyrosine kinase created by fusion of the PDGFRA and FIP1L1 genes as a therapeutic target of imatinib in idiopathic hypereosinophilic syndrome [J].

Cools, J ;

DeAngelo, DJ ;

Gotlib, J ;

Stover, EH ;

Legare, RD ;

Cortes, J ;

Kutok, J ;

Clark, J ;

Galinsky, I ;

Griffin, JD ;

Cross, NCP ;

Tefferi, A ;

Malone, J ;

Alam, R ;

Schrier, SL ;

Schmid, J ;

Rose, M ;

Vandenberghe, P ;

Verhoef, G ;

Boogaerts, M ;

Wlodarska, I ;

Kantarjian, H ;

Marynen, P ;

Coutre, SE ;

Stone, R ;

Gilliland, DG .

NEW ENGLAND JOURNAL OF MEDICINE, 2003, 348 (13) :1201-1214

[2] Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia. [J].

Druker, BJ ;

Talpaz, M ;

Resta, DJ ;

Peng, B ;

Buchdunger, E ;

Ford, JM ;

Lydon, NB ;

Kantarjian, H ;

Capdeville, R ;

Ohno-Jones, S ;

Sawyers, CL .

NEW ENGLAND JOURNAL OF MEDICINE, 2001, 344 (14) :1031-1037

[3] Treatment of hypereosinophilic syndrome with imatinib mesilate [J].

Gleich, GJ ;

Leiferman, KM ;

Pardanani, A ;

Tefferi, A ;

Butterfield, JH .

LANCET, 2002, 359 (9317) :1577-1578

[4] CHIC2 deletion, a surrogate for FIP1L1-PDGFRA fusion, occurs in systemic mastocytosis associated with eosinophilia and predicts response to imatinib mesylate therapy [J].

Pardanani, A ;

Ketterling, RP ;

Brockman, SR ;

Flynn, HC ;

Paternoster, SF ;

Shearer, BM ;

Reeder, TL ;

Li, CY ;

Cross, NCP ;

Cools, J ;

Gilliland, DG ;

Dewald, GW ;

Tefferi, A .

BLOOD, 2003, 102 (09) :3093-3096

[5] Imatinib for systemic mast-cell disease [J].

Pardanani, A ;

Elliott, M ;

Reeder, T ;

Li, CY ;

Baxter, EJ ;

Cross, NCP ;

Tefferi, A .

LANCET, 2003, 362 (9383) :535-537

[6] Differential expression of CD2 on neoplastic mast cells in patients with systemic mast cell disease with and without an associated clonal haematological disorder [J].

Pardanani, A ;

Kimlinger, TK ;

Reeder, TL ;

Li, CY ;

Tefferi, A .

BRITISH JOURNAL OF HAEMATOLOGY, 2003, 120 (04) :691-694

← 1 →